Vcanbio Cell & Gene Engineering Corp., Ltd. is a Chinese pharmaceutical company focusing on stem cell technology research and storage. With a medium-risk ESG score of 27.6, the company is dedicated to the dual-core development of 'cell + gene'. Their services include storage of various cell types, genetic testing, and more.